Avita Medical (ASX:AVH) said today that it submitted its pre-market approval application to the FDA for its ReCell autologous cell harvesting device.
The company’s system is designed to reduce the amount of skin harvesting needed to treat burn injuries compared to conventional treatments.
Get the full story at our sister site, Drug Delivery Business News.
The post Avita Medical submits PMA app for ReCell burn injury treatment appeared first on MassDevice.
from MassDevice http://ift.tt/2wZYKBn
Cap comentari:
Publica un comentari a l'entrada